Latest news with #Gorman-Rupp
Yahoo
30-07-2025
- Business
- Yahoo
What To Expect From Ingersoll Rand's (IR) Q2 Earnings
Industrial manufacturing company Ingersoll Rand (NYSE:IR) will be reporting results this Thursday after market close. Here's what investors should know. Ingersoll Rand met analysts' revenue expectations last quarter, reporting revenues of $1.72 billion, up 2.8% year on year. It was a slower quarter for the company, with full-year EBITDA guidance missing analysts' expectations and a miss of analysts' EBITDA estimates. Is Ingersoll Rand a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Ingersoll Rand's revenue to grow 2.1% year on year to $1.84 billion, slowing from the 7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.80 per share. Heading into earnings, analysts covering the company have mixed opinions about the business, with revenue estimates seeing 3 upward and 4 downward revisions over the last 30 days. Ingersoll Rand has missed Wall Street's revenue estimates five times over the last two years. Looking at Ingersoll Rand's peers in the gas and liquid handling segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Gorman-Rupp delivered year-on-year revenue growth of 5.6%, beating analysts' expectations by 2.5%, and Flowserve reported revenues up 2.7%, falling short of estimates by 3.1%. Gorman-Rupp traded up 9.9% following the results. Read our full analysis of Gorman-Rupp's results here and Flowserve's results here. There has been positive sentiment among investors in the gas and liquid handling segment, with share prices up 5.5% on average over the last month. Ingersoll Rand is up 4.7% during the same time and is heading into earnings with an average analyst price target of $93.47 (compared to the current share price of $87.07). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
30-07-2025
- Business
- Yahoo
Proto Labs (PRLB) Q2 Earnings Report Preview: What To Look For
Manufacturing services provider Proto Labs (NYSE:PRLB) will be announcing earnings results this Thursday morning. Here's what to look for. Proto Labs beat analysts' revenue expectations by 2% last quarter, reporting revenues of $126.2 million, down 1.3% year on year. It was a very strong quarter for the company, with a solid beat of analysts' adjusted operating income estimates and a solid beat of analysts' EBITDA estimates. Is Proto Labs a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Proto Labs's revenue to grow 2% year on year to $128.1 million, in line with the 2.8% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.34 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Proto Labs has missed Wall Street's revenue estimates twice over the last two years. Looking at Proto Labs's peers in the industrial machinery segment, some have already reported their Q2 results, giving us a hint as to what we can expect. GE Aerospace delivered year-on-year revenue growth of 11.6%, beating analysts' expectations by 6.5%, and Gorman-Rupp reported revenues up 5.6%, topping estimates by 2.5%. GE Aerospace traded down 1.1% following the results while Gorman-Rupp was up 9.9%. Read our full analysis of GE Aerospace's results here and Gorman-Rupp's results here. There has been positive sentiment among investors in the industrial machinery segment, with share prices up 5.5% on average over the last month. Proto Labs's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $45 (compared to the current share price of $39.66). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
30-07-2025
- Business
- Yahoo
Standex (SXI) Q2 Earnings: What To Expect
Industrial manufacturer Standex (NYSE:SXI) will be reporting results this Thursday afternoon. Here's what to look for. Standex beat analysts' revenue expectations by 1.7% last quarter, reporting revenues of $207.8 million, up 17.2% year on year. It was a satisfactory quarter for the company, with a narrow beat of analysts' EPS estimates but a slight miss of analysts' EBITDA estimates. Is Standex a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Standex's revenue to grow 19% year on year to $214.4 million, a reversal from the 4.3% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.10 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Standex has missed Wall Street's revenue estimates four times over the last two years. Looking at Standex's peers in the gas and liquid handling segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Gorman-Rupp delivered year-on-year revenue growth of 5.6%, beating analysts' expectations by 2.5%, and Flowserve reported revenues up 2.7%, falling short of estimates by 3.1%. Gorman-Rupp traded up 9.9% following the results. Read our full analysis of Gorman-Rupp's results here and Flowserve's results here. There has been positive sentiment among investors in the gas and liquid handling segment, with share prices up 5.5% on average over the last month. Standex is up 5.6% during the same time and is heading into earnings with an average analyst price target of $197 (compared to the current share price of $165.29). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio
Yahoo
24-07-2025
- Business
- Yahoo
What To Expect From Gorman-Rupp's (GRC) Q2 Earnings
Gorman-Rupp (NYSE:GRC) manufactures and sells pumps globally. will be announcing earnings results this Friday before the bell. Here's what to expect. Gorman-Rupp missed analysts' revenue expectations by 0.5% last quarter, reporting revenues of $163.9 million, up 2.9% year on year. It was a satisfactory quarter for the company, with a solid beat of analysts' EBITDA estimates. Is Gorman-Rupp a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Gorman-Rupp's revenue to grow 3% year on year to $174.6 million, improving from its flat revenue in the same quarter last year. Adjusted earnings are expected to come in at $0.57 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Gorman-Rupp has missed Wall Street's revenue estimates five times over the last two years. Looking at Gorman-Rupp's peers in the industrial machinery segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Graco delivered year-on-year revenue growth of 3.4%, missing analysts' expectations by 3.1%, and GE Aerospace reported revenues up 21.2%, topping estimates by 15.6%. GE Aerospace traded down 1.1% following the results. Read our full analysis of Graco's results here and GE Aerospace's results here. There has been positive sentiment among investors in the industrial machinery segment, with share prices up 7.7% on average over the last month. Gorman-Rupp is up 4.1% during the same time and is heading into earnings with an average analyst price target of $53 (compared to the current share price of $37.94). When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we've found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
03-06-2025
- Business
- Yahoo
3 Cash-Producing Stocks with Mounting Challenges
A company that generates cash isn't automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not all companies are created equal, and StockStory is here to surface the ones with real upside. That said, here are three cash-producing companies to steer clear of and a few better alternatives. Trailing 12-Month Free Cash Flow Margin: 10% Powering fluid dynamics since 1934, Gorman-Rupp (NYSE:GRC) has evolved from its Ohio origins into a global manufacturer and seller of pumps and pump systems. Why Does GRC Worry Us? Sales trends were unexciting over the last two years as its 7.1% annual growth was below the typical industrials company Estimated sales growth of 3.8% for the next 12 months implies demand will slow from its two-year trend Free cash flow margin shrank by 4.2 percentage points over the last five years, suggesting the company is consuming more capital to stay competitive At $36.58 per share, Gorman-Rupp trades at 17.1x forward P/E. Read our free research report to see why you should think twice about including GRC in your portfolio, it's free. Trailing 12-Month Free Cash Flow Margin: 7.4% Serving approximately 66,000 clients across 22 states with a focus on "dual eligible" Medicare and Medicaid beneficiaries, Addus HomeCare (NASDAQ:ADUS) provides in-home personal care, hospice, and home health services to elderly, chronically ill, and disabled individuals. Why Are We Wary of ADUS? Revenue base of $1.21 billion puts it at a disadvantage compared to larger competitors exhibiting economies of scale Free cash flow margin has shown no improvement over the last five years Addus HomeCare's stock price of $111.20 implies a valuation ratio of 18x forward P/E. Check out our free in-depth research report to learn more about why ADUS doesn't pass our bar. Trailing 12-Month Free Cash Flow Margin: 10% With roots dating back to 1904 and embedded in virtually every stage of scientific research and production, Avantor (NYSE:AVTR) provides mission-critical products, materials, and services to customers in biopharma, healthcare, education, and advanced technology industries. Why Are We Hesitant About AVTR? Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth Demand will likely be weak over the next 12 months as Wall Street expects flat revenue Inability to adjust its cost structure while its revenue declined over the last two years led to a 3 percentage point drop in the company's adjusted operating margin Avantor is trading at $12.96 per share, or 11.8x forward P/E. To fully understand why you should be careful with AVTR, check out our full research report (it's free). Donald Trump's victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
